Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

about

An update of safety of clinically used atypical antipsychotics.Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications.

P2860

Q36062184-A59AF55C-3E15-4767-82EF-5DCDAFB31F44 Q47555827-35717756-7918-44DE-B307-FC17342D88B9

P2860

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

Item

http://www.wikidata.org/entity/Q50593929

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@en

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@nl

type

Item

label

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@en

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@nl

prefLabel

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@en

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@nl

P1476

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

@en

P2093

Choochart Wong-Anuchit

http://www.w3.org/2001/XMLSchema#string

P2860

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Motivational interviewing: a useful approach to improving cardiovascular health?

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

Hyperprolactinemia and prolactinomas.

Prolactin and dopamine: what is the connection? A review article.

Secondary effects of antipsychotics: women at greater risk than men.

Drugs and prolactin.

Current guidelines and their recommendations for prolactin monitoring in psychosis.

P304

145-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PPC.12111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25772527

http://www.w3.org/2001/XMLSchema#string

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

about

P2860

P2860

Clinical Management of Antipsychotic-Induced Hyperprolactinemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698